News of Note—FluGen, Roswell Park Cancer Institute and The Vaccine Group

FluGen rounds up more cash, FDA awards a new orphan drug designation and The Vaccine Group forms.

> Madison, Wisconsin-based FluGen reeled in $5.5 million as it prepares for three tests on a universal flu vaccine candidate next year. Xconomy story

> The FDA awarded an orphan drug designation for a glioblastoma vaccine candidate developed at the Roswell Park Cancer Institute. Release

> A spinoff from the University of Plymouth dubbed The Vaccine Group formed to work on vaccines against pathogens such as avian influenza A, Ebola and Marburg viruses, MERS and SARS. Release

Read more on